跳至主要内容
临床试验/PACTR202101615120643
PACTR202101615120643招募中未知

Impact of Systematic Early Tuberculosis (TB) Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries

Inserm0 个研究点目标入组 3,780 人开始时间: 2019年2月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
Inserm
入组人数
3,780

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 Month(s) 至 23 Month(s)(—)
性别
All

入选标准

  • 1. Children aged 2 to 59 months
  • 2. Newly hospitalized for severe pneumonia defined using WHO criteria as cough or difficulty in breathing with:
  • o Peripheral oxygen saturation < 90% or central cyanosis, or
  • o Severe respiratory distress (e.g. grunting, nasal flaring, very severe chest indrawing), or
  • o Signs of pneumonia, defined as cough or difficulty in breathing with fast breathing (tachypnea)2 and/or chest indrawing, with any of the following danger signs:
  • a) Inability to breastfeed or drink,
  • b) Persistent vomiting
  • c) Lethargy or reduced level of consciousness
  • d) Convulsions,
  • e) Stridor in calm child
  • f) Severe malnutrition
  • 3. Informed consent signed by parent/guardian

排除标准

  • Ongoing TB treatment or history of intake of anti-TB drugs in the last 6 months

研究者

发起方
Inserm

相似试验